VXRT vs. CYCN
VXRT (Vaxart, Inc.) and CYCN (Cyclerion Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, VXRT returned -40.42%/yr vs -43.20%/yr for CYCN. Their 0.08 correlation means their historical movements had little consistent relationship.
Performance
VXRT vs. CYCN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VXRT achieves a 55.89% return, which is significantly lower than CYCN's 170.87% return.
VXRT
- 1D
- 2.46%
- 1M
- -15.63%
- 6M
- -6.86%
- YTD
- 55.89%
- 1Y
- 51.77%
- 3Y*
- -11.52%
- 5Y*
- -40.42%
- 10Y*
- —
- ALL TIME*
- -27.88%
CYCN
- 1D
- -1.71%
- 1M
- 0.29%
- 6M
- 152.94%
- YTD
- 170.87%
- 1Y
- 32.63%
- 3Y*
- 1.39%
- 5Y*
- -43.20%
- 10Y*
- —
- ALL TIME*
- -47.56%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $64.32K | $78.06K | $115.62K | |
VXRT Vaxart, Inc. | $154.47K | $165.76K | $219.97K |
VXRT vs. CYCN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
VXRT Vaxart, Inc. | 55.89% | -47.68% | 15.59% | -40.39% | -84.67% | 9.81% | 1,529.10% | -82.82% |
CYCN Cyclerion Therapeutics, Inc. | 170.87% | -60.56% | -3.88% | -74.47% | -61.85% | -43.79% | 12.50% | -86.07% |
Correlation
The correlation between VXRT and CYCN is 0.06, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.06 |
Correlation (3Y) Balances recent behavior with more history. | 0.03 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.09 |
Correlation (All Time) Calculated using the full available price history since Apr 2, 2019 | 0.08 |
Fundamentals
VXRT:
$130.70M
CYCN:
$14.90M
VXRT:
$0.16
CYCN:
-$0.59
VXRT:
0.49
CYCN:
6.13
VXRT:
1.39
CYCN:
2.13
VXRT:
$255.61M
CYCN:
$1.99M
VXRT:
$193.63M
CYCN:
$1.99M
VXRT:
$45.63M
CYCN:
-$6.70M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VXRT vs. CYCN — Risk / Return Rank
VXRT
CYCN
VXRT vs. CYCN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vaxart, Inc. (VXRT) and Cyclerion Therapeutics, Inc. (CYCN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VXRT | CYCN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.43 | ||
| Sortino ratioReturn per unit of downside risk | -2.12 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.48 | -0.29 |
| Calmar ratioReturn relative to maximum drawdown | 1.06 | 0.45 | +0.61 |
| Martin ratioReturn relative to average drawdown | 2.52 | 0.64 | +1.88 |
Loading charts...
Drawdowns
VXRT vs. CYCN - Drawdown Comparison
The maximum VXRT drawdown since its inception was -98.71%, roughly equal to the maximum CYCN drawdown of -99.72%. Use the drawdown chart below to compare losses from any high point for VXRT and CYCN.
Loading charts...
Drawdown Indicators
| VXRT | CYCN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.71% | -99.72% | +1.01% |
Max Drawdown (1Y)Largest decline over 1 year | -43.74% | -66.77% | +23.03% |
Max Drawdown (3Y)Largest decline over 3 years | -78.72% | -82.99% | +4.27% |
Max Drawdown (5Y)Largest decline over 5 years | -96.94% | -98.45% | +1.51% |
Current DrawdownCurrent decline from peak | -97.69% | -99.12% | +1.43% |
Average DrawdownAverage peak-to-trough decline | -83.17% | -88.61% | +5.44% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.26% | 46.37% | -28.11% |
Volatility
VXRT vs. CYCN - Volatility Comparison
Vaxart, Inc. (VXRT) has a higher volatility of 22.10% compared to Cyclerion Therapeutics, Inc. (CYCN) at 14.24%. This indicates that VXRT's price experiences larger fluctuations and is considered to be riskier than CYCN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VXRT | CYCN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.10% | 14.24% | +7.86% |
Volatility (6M)Calculated over the trailing 6-month period | 50.47% | 154.47% | -104.00% |
Volatility (1Y)Calculated over the trailing 1-year period | 87.77% | 326.92% | -239.15% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 92.48% | 229.41% | -136.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 127.94% | 202.24% | -74.30% |
Dividends
VXRT vs. CYCN - Dividend Comparison
Neither VXRT nor CYCN has paid dividends to shareholders.
Financials
VXRT vs. CYCN - Financials Comparison
This section allows you to compare key financial metrics between Vaxart, Inc. and Cyclerion Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
VXRT and CYCN have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VXRT has higher volatility (22.10%) compared to CYCN (14.24%). In terms of maximum drawdown, VXRT dropped -98.71% vs CYCN's -99.72%.
VXRT currently has the higher Sharpe Ratio (0.53 vs 0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VXRT and CYCN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer